No need for ivermectin clinical trial in PH — DOST

Aileen Cerrudo   •   April 10, 2021   •   1680

MANILA, Philippines—There is no need to conduct clinical trials in the Philippines for ivermectin, according to the Department of Science and Technology (DOST).

The DOST’s  Philippine Council for Health Research and Development (PCHRD) said there are already clinical trials being conducted around the world to determine the effectivity of ivermectin in treating the coronavirus disease (COVID-19).

“There are almost 20 completed and 40 ongoing clinical trials around the world as reported in exploring the use of Ivermectin formulations against COVID-19,” the department said in a statement.

The DOST explained that clinical trial projects will require a minimum of 6 months and can extend to years.

“It would be appropriate to await the results of these studies that are already significantly advanced in terms of data collection and conducting interim analyses,” the department further said. AAC



Ivermectin clinical trials to push through this September despite delays — DOST

Marje Pelayo   •   September 6, 2021

MANILA, Philippines — The Department of Science and Technology (DOST) said preparations are almost done for the start of the ivermectin clinical trial this month.

The clinical trial is necessary to find out if the controversial drug is effective against COVID-19, Dr. Jaime Montoya of the DOST-Philippine Council for Health Research and Development (PCHRD) said.

During the Laging Handa public briefing, Montoya said the agency had to adjust its protocol based on the standards of the international consortium before it launches the clinical trial for ivermectin.

“Dahil po may mga nag-review ng ating mga protocol na galing sa international reviewers po ay binago po natin ang ilang aspeto sa ating protocol para mapaganda pa po ito,” Montoya said.

Montoya added that the clinical trial for ivermectin in the country is supported by major international health bodies like the World Health Organization (WHO), the National Institute on Health, and the Centers for Disease Control (CDC).

Also, he noted the importance of the clinical trial to come up with evidence on its effectiveness against COVID-19, with Filipinos as the concentration of the trial.

“Napakahalaga na magkaroon tayo ng lokal na datos tungkol sa mga Pilipino na nabibigyan ng gamot na ito, tungkol sa safety issue, sa mga side effects, kung ito po ay totoong mabisa sa mga Pilipinong may COVID-19,” he said.

“Kailangan gumawa pa ng clinical trial para magkaroon ng sapat na ebidensya kung ito ba ay magagamit o hindi para sa COVID-19,” he added.

Currently, the DOST’s requirements are being evaluated by the consortium’s ethics committee.

Once it is finished, the DOST hopes the clinical trial for ivermectin will push through this month as initially planned.

“Ito po sa kasalukuyan ay tinatapos na ang ethics at technical review bago po ito magsimula dahil ang target natin ay this month po ‘yan dapat magsimula,” he said.

DOH, muling iginiit na hindi gamot ang ivermectin vs COVID-19

Robie de Guzman   •   August 23, 2021

MANILA, Philippines — Inulit ng Department of Health (DOH) ang babala nito hinggil sa basta-bastang pag-inom ng ivermectin bilang gamot sa COVID-19.

Ginawa ng DOH ang pahayag matapos sabihin ng United States Food and Drug Administration (USFDA) na hindi dapat gamitin kontra COVID-19 ang ivermectin na isang animal grade o ginawa para gamutin ang parasitic infection sa mga hayop.

“Ito pong gamot na ito nagpakita na po ng ebidensya na ito pong gamot na ito doesn’t give you any benefit at all in preventing, in shortening the duration of your hospitalization or preventing the progression of your disease when you have COVID-19” ani DOH Undersecretary Maria Rosario Vergeire.

“Itong gamot na ito ay may side effects in na harmful sa inyong katawan,” dagdag pa niya.

Ang babala ng USFDA ay kasunod ng mga pagdami ng mga kaso ng umano’y naoospital sa Amerika dahil sa paggamit ng ivermectin kontra COVID-19.

Sa estado ng Mississippi, iniulat ng Poison Control Center na 70% ng tawag na kanilang natatanggap ay dahil sa pag-inom ng animal grade na ivermectin na binili sa livestock centers.

Ayon sa ahensya, hindi dapat inumin ng mga tao ang animal drugs dahil ito ay concentrated para sa mga malalaking hayop at toxic para sa tao.

Una na ring nagbabala ang World Health Organization laban sa paggamit ng ivermectin bilang gamot sa COVID-19, maliban na lamang kung ito ay para sa isang clinical trial. RRD (mula sa ulat ni Correspondent Aiko Miguel)

Philippines, all set for WHO Solidarity trials on COVID vaccines — DOST

Marje Pelayo   •   July 13, 2021

MANILA, Philippines — The Department of Science and Technology (DOST) has confirmed the signing of a letter of agreement for the conduct of the World Health Organization’s (WHO) solidarity trials for COVID-19 vaccines in the Philippines.

“Nagpirmahan na [ng letter of agreement]. Pormal na po ang ating pagsasagawa nito,” said DOST Undersecretary Rowena Guevara in an interview in Laging Handa Press Briefing Tuesday (July 13).

“Sinasabi po dito na makakadiskubre tayo ng pinaka-epektibong COVID-19 vaccines na naaayon sa pangangailangan ng Filipino population,” she added.

The official said the WHO has already given its final clinical trial protocol, standard operating procedures, and four investigational brochures of the vaccines that will be put under a study in the duration of the trial.

She added that the DOST Solidarity Vaccine Trial team has submitted its requirement for review of the vaccine expert panel, the single-joint ethics review board, and the regulatory review of the Food and Drug Administration (FDA).

For the vaccine mix-and-match, Guevarra said they will be using all COVID vaccines available in the Philippines.

The official said they already listed 3,000 participants for the entire mix-and-match project which is proposed to be conducted in eight sites including Manila, Pasig City, Antipolo, Marikina City, Makati, Pasay City, Quezon City, Muntinlupa, Cebu City, and Davao City.

“Para masiguro ang consistency at uniformity sa trial, ang ilalahok lamang ay ang mga hindi pa nabibigyan ng COVID-19 na bakuna,” Guevarra said.

“Kapag ang mga bagong bakuna ay pumasa na sa Phase 3 na may satisfactory result, maaari na po silang isama sa pagpipilian ng Pilipinas at ibang bansa sa pag-deploy para sa kani-kanilang vaccination programs,” she added.

At present, Guevarra said there are four FDA-approved clinical trials in the Philippines, while seven new vaccine clinical trial applications are now in different stages of review by the vaccine panel of experts, single-joint ethics review board, and the FDA.

Guevara stressed that clinical trials are being conducted to assess and investigate the efficacy, safety, and immunogenicity of the vaccines.


The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel) (General inquiries)


UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.